Last Updated On 1/26/2025 4:51:27 PM
This is a disclosure report of the user financial relationships with for-profit health care companies.
All relationships are considered compensated unless otherwise noted. Relationships are self-held unless otherwise noted.
| Employment |
| No Relationships to Disclose |
|
|
| Leadership |
| No Relationships to Disclose |
|
|
| Stock and Other Ownership Interests |
| No Relationships to Disclose |
|
|
| Honoraria |
| Company: Merck Sharp & Dohme |
| Recipient: You |
| Company: Eisai |
| Recipient: You |
| Company: Exelixis |
| Recipient: You |
| Company: Sun Pharma Advanced Research Company |
| Recipient: You |
| Company: PDS Biotechnology |
| Recipient: You |
| Company: Merus |
| Recipient: You |
|
| Consulting or Advisory Role |
| Company: Merck |
| Recipient: You |
| Company: Exelixis |
| Recipient: You |
| Company: Sun Pharma Advanced Research Company |
| Recipient: You |
| Company: Adlai Nortye |
| Recipient: You |
| Company: Coherus Biosciences |
| Recipient: You |
| Company: Coherus Biosciences |
| Recipient: You |
| Company: PDS Biotechnology |
| Recipient: You |
|
| Speakers' Bureau |
| No Relationships to Disclose |
|
|
| Research Funding |
| Company: Adlai-Nordlyte |
| Recipient: You |
| Company: PDS Biotechnology |
| Recipient: You |
| Company: coherus |
| Recipient: You |
| Company: EpicentRx |
| Recipient: You |
| Company: Merck |
| Recipient: Your Institution |
| Company: CUE Biopharma |
| Recipient: Your Institution |
| Company: Loxo/Lilly |
| Recipient: Your Institution |
|
| Patents, Royalties, Other Intellectual Property |
| No Relationships to Disclose |
|
|
| Expert Testimony |
| No Relationships to Disclose |
|
|
| Travel, Accommodations, Expenses |
| Company: Merck Sharp & Dohme |
| Recipient: You |
| Company: Sun Pharma Advanced Research Company |
| Recipient: You |
|
| Other Relationship |
| No Relationships to Disclose |
|
|
| (OPTIONAL) Uncompensated Relationships |
| No Relationships to Disclose |
|
|
| (OPTIONAL) Open Payments Link |
| No Relationships to Disclose |
|
|